Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kibbler

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|June 24, 1998
Removing intravascular lines at 72 hours allows need for antibiotics to be reassessedM Ruddy, C C Kibbler
The New England Journal of Medicine|October 9, 1999
Liposomal amphotericin B for fever and neutropeniaH G Prentice, C C Kibbler
Current Opinion in Infectious Diseases|October 13, 2006
Pathogen 'shift' in febrile neutropeniaC C Kibbler, H G Prentice
BMJ (Clinical Research Ed.)|April 6, 1991
DIY microbiologyC C Kibbler, S H Gillespie
The Journal of Hospital Infection|July 4, 1998
The epidemiology and prevention of invasive aspergillosisR J Manuel, C C Kibbler
Current Opinion in Infectious Diseases|October 13, 2006
A reappraisal of current approaches to the management of fungal infections in neutropenic patientsC C Kibbler, H G Prentice
Current Opinion in Infectious Diseases|April 20, 2002
What is the risk of transfusing micro-organisms during stem cell transplantation?Christopher C. Kibbler, H. Grant Prentice
The Journal of Antimicrobial Chemotherapy|December 1, 1988
Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxisP Mannan, C C Kibbler, P Noone
BMJ (Clinical Research Ed.)|August 23, 1997
Prophylactic and empirical antifungal treatment in cancer complicated by neutropenia. Combining different antifungal strategies in same systematic review is inappropriateC C Kibbler, R Manuel, H G Prentice
Alimentary Pharmacology & Therapeutics|April 2, 1999
Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP)J M Subhani, C Kibbler, J S Dooley
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|June 24, 1998
Removing intravascular lines at 72 hours allows need for antibiotics to be reassessedM Ruddy, C C Kibbler
The New England Journal of Medicine|October 9, 1999
Liposomal amphotericin B for fever and neutropeniaH G Prentice, C C Kibbler
Current Opinion in Infectious Diseases|October 13, 2006
Pathogen 'shift' in febrile neutropeniaC C Kibbler, H G Prentice
BMJ (Clinical Research Ed.)|April 6, 1991
DIY microbiologyC C Kibbler, S H Gillespie
The Journal of Hospital Infection|July 4, 1998
The epidemiology and prevention of invasive aspergillosisR J Manuel, C C Kibbler
Current Opinion in Infectious Diseases|October 13, 2006
A reappraisal of current approaches to the management of fungal infections in neutropenic patientsC C Kibbler, H G Prentice
Current Opinion in Infectious Diseases|April 20, 2002
What is the risk of transfusing micro-organisms during stem cell transplantation?Christopher C. Kibbler, H. Grant Prentice
The Journal of Antimicrobial Chemotherapy|December 1, 1988
Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxisP Mannan, C C Kibbler, P Noone
BMJ (Clinical Research Ed.)|August 23, 1997
Prophylactic and empirical antifungal treatment in cancer complicated by neutropenia. Combining different antifungal strategies in same systematic review is inappropriateC C Kibbler, R Manuel, H G Prentice
Alimentary Pharmacology & Therapeutics|April 2, 1999
Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP)J M Subhani, C Kibbler, J S Dooley
Pageof 14